BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 190887)

  • 1. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous estrogens and endometrial cancer.
    Gordan GS; Greenberg BG
    Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer and estrogen use. Report of a large case-control study.
    Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
    N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term estrogen replacement therapy. II. Neoplasia.
    Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and endometrial carcinoma.
    Gray LA; Christopherson WM; Hoover RN
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of exogenous estrogen therapy and endometrial cancer.
    Jelovsek FR; Hammond CB; Woodard BH; Draffin R; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1980 May; 137(1):85-91. PubMed ID: 7369293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases.
    Spengler RF; Clarke EA; Woolever CA; Newman AM; Osborn RW
    Am J Epidemiol; 1981 Oct; 114(4):497-506. PubMed ID: 7304580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal estrogens and breast cancer.
    Hoover R; Gray LA; Cole P; MacMahon B
    N Engl J Med; 1976 Aug; 295(8):401-5. PubMed ID: 180409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of endometrial cancer.
    Voigt LF; Weiss NS
    Cancer Treat Res; 1989; 49():1-21. PubMed ID: 2577197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for adenomatous endometrial hyperplasia: a case-control study.
    Kreiger N; Marrett LD; Clarke EA; Hilditch S; Woolever CA
    Am J Epidemiol; 1986 Feb; 123(2):291-301. PubMed ID: 3946378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasia and hormonal contraception.
    Huggins GR
    Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.